Usefulness and Safety Evaluation of Chemotherapy Administration Device for Nurses: Experimental Study.

Chemotherapy administration Device usefulness Medication error Nurses attitude Patient safety

Journal

Seminars in oncology nursing
ISSN: 1878-3449
Titre abrégé: Semin Oncol Nurs
Pays: United States
ID NLM: 8504688

Informations de publication

Date de publication:
08 2022
Historique:
received: 20 11 2021
accepted: 03 05 2022
pubmed: 3 6 2022
medline: 3 8 2022
entrez: 2 6 2022
Statut: ppublish

Résumé

Antineoplastic drugs are considered high risk, and computerized systems favor safe administration. The objective of the study was to test the usefulness and safety of a new mobile device compared to the standard device for administering these antineoplastic treatments. This multicenter, quasi-experimental pre-post study assessed an intervention in two cancer centers in June and July 2020. Nineteen nurses participated by completing 57 questionnaires. The outcome variables were usefulness, ease of use, efficiency, safety, attitudes, and satisfaction with the new mobile device; they were measured by means of the USE questionnaire (Usefulness, Satisfaction, and Ease of use) and the Technology Attitude Survey (TAS). Professionals rated the new device higher than the standard device and showed a favorable attitude toward technology. The tested device was useful, effective, safe, and specific to the antineoplastic treatment administration process, garnering greater satisfaction among professionals than the standard. As new technologies can improve care for patients with cancer, it is essential to develop strategies to improve the experience of professionals for optimal implementation.

Identifiants

pubmed: 35654628
pii: S0749-2081(22)00057-2
doi: 10.1016/j.soncn.2022.151298
pii:
doi:

Substances chimiques

Antineoplastic Agents 0

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

151298

Informations de copyright

Copyright © 2022 Elsevier Inc. All rights reserved.

Auteurs

M Antònia Serra-Barril (MA)

Catalan Institute of Oncology, Quality Practice Department, Barcelona, Spain; Faculty of Medicine and Health Sciences, School of Nursing, University of Barcelona, Fundamental Care and Medical-Surgical Nursing Department, Barcelona, Spain. Electronic address: maserra@iconcologia.net.

Marta Pamias-Nogue (M)

Catalan Institute of Oncology, Outpatient Treatment Unit, L'Hospitalet-Barcelona, Spain.

Núria Zarza-Arnau (N)

Catalan Institute of Oncology, Outpatient Treatment Unit, L'Hospitalet-Barcelona, Spain.

Anna Esteve-Gomez (A)

Catalan Institute of Oncology, Scientific Knowledge and Research Department, L'Hospitalet-Barcelona, Spain.

Ana Clopes-Estela (A)

Catalan Institute of Oncology, Scientific Knowledge and Research Department, L'Hospitalet-Barcelona, Spain; Catalan Institute of Oncology, Pharmacy and Drug Policy Department, L'Hospitalet-Barcelona, Spain.

Paz Fernández-Ortega (P)

Catalan Institute of Oncology, Scientific Knowledge and Research Department, L'Hospitalet-Barcelona, Spain; Faculty of Medicine and Health Sciences, Department of Public Health, Mental Health and Maternal Care, University of Barcelona, L'Hospitalet-Barcelona, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH